Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Protecting Access to Medicare Act of 2014 Could Harm Independent Community Labs

Many factors involved in Medicare protection act’s lab market data reporting

In the Protecting Access to Medicare Act of 2014 (PAMA), the Center for Medicare and Medicaid Services (CMA) is directed to collect market price data and use the data to establish prices for the Part B Clinical Laboratory Fee Schedule, starting on January 1, 2017.

To access this post, you must purchase The Dark Report.

Comments

;